Abstract
Gout in older patients tends to be sub-acute to chronic, often tophaceous, polyarticular, erosive, symmetrical, and causes persistent, recurrent and chronic arthritis. Clinically, it may closely mimic rheumatoid arthritis; thus, a correct diagnosis requires a high index of clinical suspicion and the identification of uric acid crystals. An optimal therapeutic strategy for most older patients with chronic tophaceous gout could involve the following: avoidance of alcohol and diuretic use if possible; avoidance of long term nonsteroidal anti-inflammatory drug (NSAID) therapy; use of short term corticosteroids (systemic or intra-articular) for acute exacerbations; prophylactic colchicine daily or every other day according to the degree of renal dysfunction present; and long term allopurinol therapy in dosages adjusted to the degree of hyperuricaemia and renal dysfunction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 128-134 |
| Number of pages | 7 |
| Journal | Drugs & Aging |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1994 |
| Externally published | Yes |
ASJC Scopus subject areas
- Geriatrics and Gerontology
- Pharmacology (medical)